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ABSTRACT
BACKGROUND AND PURPOSE: Intraplaque hemorrhage within intracranial atherosclerotic plaques identified by high-resolution MR
imaging has been studied as a potentialmarker of stroke risk. However, previous studies only examined intracranial arterieswith high-grade
stenosis (degree of stenosis,50%). This study aimed to ascertain the clinical relevance of intraplaque hemorrhage in patients with low-
and high-grade stenotic basilar artery plaques.
MATERIALS ANDMETHODS: Patients with basilar artery stenosis (n 126; mean age, 62 10 years; 66 symptomatic and 60 asymptom-
atic) underwent high-resolution MR imaging. The relationship between imaging findings (intraplaque hemorrhage, contrast enhancement,
degree of stenosis, minimal lumen area, and plaque burden) and symptoms was analyzed.
RESULTS: Intraplaque hemorrhagewas identified in 22 patients (17.5%), including 21 (31.8%) symptomatic patients and 1 (1.7%) asymptomatic
patient. Multivariate analysis showed that intraplaque hemorrhage was the strongest independent marker of symptomatic status (odds
ratio, 27.5; 95% CI, 3.4–221.5; P .002). Contrast enhancement was also independently associated with symptomatic status (odds ratio, 9.9;
95% CI, 1.5–23.6; P  .016). Stenosis, minimal lumen area, and plaque burden were not correlated with symptoms (P  .05). Intraplaque
hemorrhage was present in both low- and high-grade stenotic basilar arteries (11.3% versus 16.3%, P .63). Diagnostic performance values
of intraplaque hemorrhage for patients with acute/subacute symptomatic stroke were the following: specificity, 98.3%; sensitivity, 31.8%;
positive predictive value, 95.5%; and negative predictive value, 56.7%.
CONCLUSIONS: Intraplaque hemorrhage is present in both low- and high-grade stenotic basilar artery plaques and is independently
associated with symptomatic stroke status. Intraplaque hemorrhage may identify high-risk plaque and provide new insight into the
management of patient with stroke without significant stenosis.
ABBREVIATIONS: HR-MRI high-resolution MR imaging; ICAD intracranial atherosclerotic disease; IPH intraplaque hemorrhage
Intracranial atherosclerotic disease (ICAD) is a major cause ofstroke that has likely been underappreciated, in part due to
challenges in detecting intracranial atherosclerotic plaque.1 ICAD
may produce ischemia through multiple mechanisms, including
the following: thrombotic occlusion, occlusion of small perforat-
ing arteries, plaque rupture leading to artery-to-artery emboliza-
tion, and vessel luminal narrowing leading to hypoperfusion.2
Current practice guidelines rely solely on the degree of stenosis
(often50%) of major intracranial arteries in determining man-
agement strategies. However, many authors have questioned this
practice, especially given the high prevalence at postmortem ex-
amination of mild and moderate intracranial arterial stenosis in
fatal stroke.2-6 Branch occlusive disease, in particular, has been
underestimated and appears to constitute a more common cause
of stroke.5 Other factors, including plaque composition, arterial
hemodynamic features, and collateral status, have been proposed
as alternative variables to better predict recurrent stroke risk.4
ICAD with ischemia caused by artery-to-artery embolization
from plaque rupture may require more aggressive antiplatelet
therapy to mitigate clot progression, whereas stenotic disease re-
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sulting in hypoperfusion might benefit more from angioplasty.2
Given these important distinctions in treatment selection for pa-
tients with ICAD based on stroke mechanism, the assessment of
culprit plaque location and morphology is clinically relevant.2 In
the past decade, many advances have been made in visualizing
large-vessel intracranial plaquemorphology and composition us-
ing high-resolution MR imaging (HR-MRI).7,8 Expanded use of
HR-MRI could result in the reclassification of many strokes pre-
viously termed cryptogenic and could improve clinical decision-
making. A few studies have examined atherosclerotic plaque of
the posterior circulation using HR-MRI with improved charac-
terization of basilar artery ICAD.9-13
Intraplaque hemorrhage (IPH) occurs in atherosclerotic
plaque and is attributed to fragile neovascularity with endothelial
disruption that increases plaque wall stress, making plaque more
vulnerable.14 IPH was first identified as a T1-weighted hyperin-
tense signal in extracranial carotid plaque imaging,15 and subse-
quent articles have supported carotid IPH as a risk factor for re-
current stroke independent of stenosis.16,17 Preliminary work
using intracranial HR-MRI showed a similar appearance of IPH
within intracranial arteries in symptomatic ICAD.18 Xu et al19
observed T1-weighted hyperintense signal more often in symp-
tomatic middle cerebral artery plaque than in asymptomatic
plaques. More recently, in patients with basilar artery stenosis,
HR-MRI has revealed IPH as more frequent in symptomatic pa-
tients than in asymptomatic patients (42.3% versus 21.4%), sug-
gesting a risk for IPH with a relative risk of 1.64.12
These prior basilar artery HR-MRI studies have only imaged
basilar artery plaquewith high-grade stenosis. The primary aimof
this study was to ascertain the presentation and clinical relevance
of basilar artery IPH in both low- and high-grade stenotic basilar
artery plaques. Given the frequency of nonstenotic ICAD in
stroke and preliminary evidence supporting IPH as a risk factor,
we hypothesize that IPH status might be useful in distinguishing
acute/subacute symptomatic from chronic/asymptomatic basilar
artery plaque regardless of the degree of stenosis.
MATERIALS AND METHODS
The authors declare that all supporting data are available within
the article.
Study Population
This study was approved by the Changhai Hospital institutional
review board with all patients providing written informed
consent.
This was a prospective study. Patients with basilar artery ath-
erosclerotic disease were recruited for this study between Septem-
ber 2013 and October 2016. The inclusion criteria were the fol-
lowing: 1) ischemic stroke or transient ischemic attacks in the
basilar artery territory, and/or basilar artery stenosis of30% on
DSA, CTA, orMRA; and 2)1 atherosclerotic risk factor, includ-
ing hypercholesterolemia, hypertension, smoking, and diabetes
mellitus. Exclusion criteria included the following: 1) coexistent
unilateral or bilateral vertebral artery stenosis of50% onMRA,
2) complete basilar artery occlusion, 3) dissection, 4) intracranial
dolichoectasia, 5) nonatherosclerotic intracranial arterial disease
(eg, inflammatory arteritis and congenital agenesis), 6) the pres-
ence of atrial fibrillation on 24-hour monitoring, and 7) clinical
contraindications to MR imaging.
Symptomatic plaque was defined when conventional neuro-
imaging (FLAIR and diffusion-weighted images) demonstrated
infarct within the basilar artery territory. Patients were classified
into 2 groups based on their symptom presentation: 1) symptom-
atic ischemic stroke/TIA symptoms presenting12 weeks before
imaging; and 2) patients with asymptomatic basilar artery plaque
without neuroimaging evidence of infarct.
Patients’ clinical information including age, sex, diabetes, hy-
pertension, smoking, hyperlipidemia, preadmission statin and as-
pirin use, ischemic coronary heart disease, andNational Institutes
of Health Stroke Scale score was collected.
MR Imaging Protocol
MR imaging was performed on a 3T whole-body MR imaging
scanner (Skyra; Siemens, Erlangen, Germany) with a 20-channel
phased array head and neck coil.
3D time-of-flight images were acquired in the axial plane (TR/
TE  21/3.43 ms, FOV  181  200 mm, thickness  0.7 mm,
matrix  331  384). 3D TOF images were reformatted using
multiplanar reconstruction. HR-MRI was then performed in
planes perpendicular to the basilar artery. The HR-MRI protocol
included 3 sequences with 1 sequence repeated postcontrast (12
slices with 2-mm slice thickness; in-plane resolution 0.4 0.3
mm, FOV  100  100 mm, matrix  256  320); precontrast
T1-weighted fast spin-echo (TR/TE  581/18 ms, echo-train
length 4, NEX 4); T2-weighted FSE (TR/TE 2890/46 ms,
echo-train length 20, NEX 3); and postcontrast T1-weighted
FSE. Inflow saturation bands were placed below the imaging slab
for blood suppression. In addition, 12 coronal slices were scanned
with similar scan parameters to help exclude the potential IPH-
mimicking flow artifacts. Clinical DWI and FLAIR imaging were
used for the identification of infarct.
Image Analysis
Stenosis value was measured independently on HR-MRI by 2
experienced radiologists (X.T. and Q.L., with 7 and 15 years’ ex-
perience in neuroradiology) who were blinded to the patients’
clinical information.20 The stenosis value was calculated as (1 
DStenosis /DNormal) 100%, whereDStenosis is theminimal lumen
diameter at the site of maximal stenosis, andDNormal is the lumen
diameter at the site of the normal basilar artery (either distal or
proximal to the stenosis site). The presence of fresh IPHwas iden-
tified as 150% signal relative to nearby medial pterygoid mus-
cles on precontrast T1-weighted images by the 2 radiologists in-
dependently, blinded to the patient’s clinical information.12
Because intraluminal thrombus/hematoma in intracranial
dolichoectasia or dissection also exhibits hyperintense signal on
precontrast T1-weighted images, we carefully excluded these con-
ditions on the basis of their imaging features.21,22 Basilar dolicho-
ectasia was identified if the basilar diameter was enlarged4 mm
and demonstrated a tortuous appearance on MRA.21 Dissection
might appear with a dissection flap or double lumen or as a taper-
ing vessel; intraluminal thrombus in dissection also usually in-
volves a long segment.22 Acute or subacute thrombus demon-
strates different morphology compared with IPH. Thrombus is
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long and close to the lumen, while IPH is focal within plaque and
is often eccentric to the lumen.
The lumen andouterwall boundaryweremanually segmented
using CMRtools software (Cardiovascular Imaging Solutions,
London, UK) on T2-weighted images. The reproducibility of this
area measurement method was previously reported (measure-
ment error for plaque area: 7.5%).23
The contrast-enhancement percentage was measured at the
slice of greatest enhancement, using adjacent gray matter (in a
region of15 mm2) to normalize signal intensity. The contrast-
enhancement percentage was calculated as {[Signal of Plaque
(Postcontrast) / Signal of GrayMatter (Postcontrast)] / [Signal of
Plaque (Precontrast) / Signal of Gray Matter (Precontrast)] 
1} 100%. Plaque burdenwasmeasured on themaximal stenosis
site and was defined as (1 Lumen Area / Outer Area) 100%.
Statistical Analysis
Normality assumptions were formally assessed using a Shapiro-
Wilk test. Distributions were summarized using the mean  SD
or median (interquartile range). Categoric data were expressed as
counts or percentages. Continuous data
were compared using either a Mann-
Whitney U test or a Student t test. Cate-
goric variables were analyzed using the
Fisher exact test.Multivariate logistic re-
gression analysis was used to determine
the independent factors associated with
acute/subacute symptoms. The intra-
class correlation coefficient and Cohen
 coefficient were used to evaluate the
agreement between 2 reviewers for the
measurement of the degree of stenosis
and the identification of IPH. A P value
of  .05 was considered statistically
significant. All P values were 2-sided.
GraphPad Prism 5 software (GraphPad
Software, San Diego, California) and R
statistics (Version 3.1.3; www.r-project.
org) were used for data analysis.
RESULTS
Patients, Demographics, and
Imaging Findings
A total of 175 patients met the inclusion
criteria. Forty-nine patients were ex-
cluded due to intracranial aneurysms
(n  28), Moyamoya disease (n  3),
vasculitis (n  1), dissection (n  6),
coexistent vertebral artery stenosis50%
(n 8), and bad image quality (n 3).
As a result, 126 patients were included in
the final analysis (mean age, 61.5 10.0
years; 82 males; mean degree of stenosis
of 52.6%  15.8%). A total of 66 pa-
tients were symptomatic, and 60 were
asymptomatic. Forty-six patients had a
degree of stenosis of 50% (low-grade
stenosis; range, 13.4%–48.7%), while 80
patients had a degree of stenosis of 50% (high-grade stenosis;
range, 50.1%–80.3%). Demographic information and imaging
findings are summarized in Tables 1 and 2 on the basis of the
patients’ degree of stenosis and symptom status.
IPH was identified in 22 patients (17.5%), including 21 symp-
tomatic patients (31.8%) and 1 (1.7%) asymptomatic patient (Ta-
ble 2). IPH appeared over a range of stenosis values (Table 1), and
there was no difference in the presentation rate of the basilar
arteries in low- and high-grade stenosis (19.6% versus 16.3%, P
.63). The IPH-to-muscle signal ratio was 2.10  0.54 (range,
1.50–3.19). In these 21 patients with stroke with IPH, 15 had
paramedian pontine infarct stroke and 6 had lacunar infarction
stroke. Univariate and multivariate analyses of the parameters
associated with symptoms are shown in Table 3. IPH was the
strongest independent indicator of symptomatic status (odds ra-
tio, 27.5; 95% CI, 3.4–221.5; P  .002). Contrast enhancement
was also independently associated with symptomatic status (odds
ratio, 9.9; 95% CI, 1.5–23.6; P .016). Degree of stenosis, mini-
mal lumen area, and plaque burden were not significantly associ-
Table 1: Clinical characteristics and imaging findings of patients with low- and high-grade
stenotic basilar artery plaque
All (n = 126)
Low-Grade
Stenosis
(<50%, n = 46)
High-Grade
Stenosis
(≥50%, n = 80)
P
Value
Age (mean) (yr) 61.5 10.0 63.70 9.4 60.3 10.1 .07
Sex (male) (No.) (%) 82 (65.1%) 33 (71.7%) 49 (61.3%) .23
Diabetes (No.) (%) 42 (33.3%) 15 (32.6%) 27 (33.8%) .90
Smoking (No.) (%) 35 (27.8%) 13 (28.3%) 22 (27.5%) .93
Hypertension (No.) (%) 101 (80.2%) 37 (80.4%) 64 (80.0%) .96
Hyperlipidemia (No.) (%) 65 (51.6%) 18 (39.1%) 47 (58.8%) .03a
Coronary artery disease (No.) (%) 5 (4.0%) 3 (6.5%) 2 (2.5%) .27
Preadmission aspirin use (No.) (%) 31 (24.6%) 9 (19.6%) 22 (27.5%) .32
Preadmission statin use (No.) (%) 17 (13.5%) 4 (8.7%) 13 (16.3%) .23
NIHSS score (median) (range) 1 (0–11) 2 (0–11) 0 (0–6) .001a
Degree of stenosis (mean) (%) 52.6 15.8 35.2 9.7 62.6 7.9 .001a
Enhancement percentage (mean) 17.4 28.4 21.1 33.1 15.3 25.3 .27
Intraplaque hemorrhage (No.) (%) 22 (17.5%) 9 (19.6%) 13 (16.3%) .63
Minimum lumen area (mean) (mm2) 3.2 2.7 5.1 3.4 2.1 1.3 .001a
Plaque burden (mean) (%) 84.0 9.1 75.9 8.2 88.6 5.7 .001a
Symptomatic (No.) (%) 66 (52.4%) 28 (60.9%) 38 (47.5%) .15
a Statistically significant.
Table 2: Clinical characteristics and imaging findings of patients with different symptom
stages
All
(n = 126)
Symptomatic
(n = 66)
Asymptomatic
(n = 60)
P
Value
Age (mean) (yr) 61.5 10.0 61.7 10.5 61.4 9.4 .86
Sex (male) (No.) (%) 82 (65.1%) 50 (75.8%) 32 (53.3%) .001a
Diabetes (No.) (%) 42 (33.3%) 23 (34.8%) 19 (31.7%) .71
Smoking (No.) (%) 35 (27.8%) 25 (37.9%) 10 (16.7%) .001a
Hypertension (No.) (%) 101 (80.2%) 52 (78.8%) 49 (81.7%) .69
Hyperlipidemia (No.) (%) 65 (51.6%) 38 (57.6%) 27 (45.0%) .16
Coronary artery disease (No.) (%) 5 (4.0%) 3 (4.5%) 2 (3.3%) .73
Preadmission aspirin use (No.) (%) 31 (24.6%) 21 (31.8%) 10 (16.7%) .06
Preadmission statin use (No.) (%) 17 (13.5%) 10 (15.2%) 7 (11.7%) .57
NIHSS score (median) (range) 1 (0–11) 2 (0–11) 0 (0–4) .001a
Degree of stenosis (mean) (%) 52.6 15.8 52.4 15.5 52.8 16.1 .88
Enhancement percentage (mean) 17.4 28.4 25.5 26.1 8.5 28.5 .001a
Intraplaque hemorrhage (No.) (%) 22 (17.5%) 21 (31.8%) 1 (1.7%) .001a
Minimum lumen area (mean) (mm2) 3.2 2.7 3.7 2.8 2.7 2.6 .04a
Plaque burden (mean) (%) 84.0 9.1 83.6 9.8 84.4 8.2 .62
a Statistically significant.
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atedwith symptoms (P .05). The pres-
ence of IPH was not associated with
stenosis (r  0.16, P  .10) or plaque
burden (r 0.16, P .11). Representa-
tive basilar artery plaque images with
and without IPH are shown in Figs 1–3.
The diagnostic performance of IPH
for acute/subacute symptomatic pa-
tients with stroke is summarized in Ta-
ble 4. IPHhad a high specificity of 98.3%
and a high positive predictive value of
95.5%; however, the sensitivity (31.8%)
and negative predictive value (56.7%)
were lower.
MR Imaging Measurements
Reproducibility
There was excellent interreader agree-
ment for measuring the degree of steno-
sis (intraclass correlation coefficient 
0.97; 95% CI, 0.94–0.98) and for iden-
tification of IPH (96% agreement,  
0.88; 95% CI, 0.76–1.00).
DISCUSSION
This study adds to the growing literature
that emphasizes the importance of in-
tracranial plaque properties compared
with the degree of luminal narrowing.2
In this study, IPH was the only finding
associated with stroke-symptom status,
whereas contrast enhancement, degree
of stenosis, minimal lumen area, and
plaque burden were not associated with
symptom status. Because IPH was pres-
ent in both low- and high-grade stenotic
basilar artery plaque with a high positive
predictive value (95.5%) for symptom-
atic stroke, it is evident that symptom-
atic ischemia may be explained by fac-
tors other than stenosis resulting in
FIG 1. Intraplaque hemorrhage presenting in a low-grade stenotic basilar artery plaque (43%
degree of stenosis) in an acute symptomatic female patient (65 years of age). A, T1-weighted
black-blood MR imaging shows high signal (fresh IPH, red arrow) in the plaque. B, Postcontrast
T1-weighted image shows slight enhancement of the plaque. C, T2-weighted image shows isoin-
tense signal of the plaque. D, DWI shows infarct in the brain stem (yellow arrow).
FIG 2. A high-grade stenotic basilar artery plaque (degree of stenosis, 73%) without intraplaque hemorrhage in an asymptomatic female patient
(56 years of age). A, T1-weighted black-blood MR imaging shows isointense signal in the plaque. B, Postcontrast T1-weighted image shows
enhancement of the plaque surface. C, T2-weighted image shows high signal of the plaque (red arrow).
Table 3: Univariate and multivariate analyses of the parameters associated with
symptomatic status
Variable
Univariate
Analysis
Multivariate
Analysis
Odds Ratio
(95% CI) P
Odds Ratio
(95% CI) P
Sex (male) 2.7 (1.2–5.8) .001
Smoking 3.0 (1.3-.7.1) .001
Enhancement percentage 13.0 (2.6–25.0) .001 9.9 (1.5–23.6) .016
Intraplaque hemorrhage 27.5 (3.6–212.4) .002 27.5 (3.4–221.5) .002
Minimum lumen area 1.2 (1.0–1.4) .04
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hypoperfusion. The presence of IPH likely indicates a high risk
for artery-to-artery embolic occlusion following plaque rupture.
In this conceptualization, future stroke risk for a smaller plaque
with IPH is possibly greater than for a larger plaque with a stable
fibrous cap.
A study of basilar artery ICAD in patients with at least 30%
stenosis found T1-weighted hyperintense intraplaque signal in 8
of 38 cases (21%), which could indicate IPH, though the authors
did not specifically term this finding IPH.9 The prevalence of basi-
lar artery T1-weighted hyperintense signal reported by Huang et
al9 (21%) was similar to that reported in the current study
(19.6%). On the other hand, a study of 74 patients with 50%
stenosis documented IPH in 42.3% of patients with an increased
frequency in symptomatic patients.12 The reason for this higher
incidence of IPH may be related to the larger plaque size in these
patients with amean stenosis of 72.9%, thoughwe did not observe
a significant difference between IPH frequency in stenotic-versus-
nonstenotic plaque in our study.12 Alternatively, patients in our
study were younger than those of Yu et al,12 with a difference in
mean age of approximately 10 years between the populations in the
2 studies. IPHmay occur more frequently with age, though this hy-
pothesis is untested.Thediagnostic performanceof IPH in the afore-
mentioned study was similar to that in the current study with rela-
tively high specificity (79%) but low sensitivity (53%).12 A study of
IPH in other intracranial arteries has observed similar findings. IPH
was significantly more frequent in symptomatic middle cerebral ar-
tery plaque than in asymptomatic plaque (19.6% versus 3.2%).19
While current management guidelines focus on stenosis, our
work and that of others supports the use of identification of
plaque properties to better indicate future stroke risk. Our study
emphasizes the highly specific (98.3%) nature of IPH as an indi-
cator of symptomatic stroke, implying that this represents unsta-
ble basilar artery atherosclerotic plaque. Unfortunately, IPH is
not particularly sensitive (31.8%) to the presence of a symptom-
atic basilar artery. These observations likely reflect the multiple
stroke mechanisms encountered in ICAD, in which IPH could
predispose to artery-to-artery embolization with small-vessel oc-
clusion and could cause branch occlusive disease affecting perfo-
rating arteries. On the other hand, some symptomatic strokes in
this study could also be caused by stenotic basilar artery plaque
leading to hypoperfusion. IPH was the best overall marker of
symptomatic plaque with an odds ratio of 27.5. The findings of
this study support the use of IPH in basilar artery atherosclerotic
plaque as a better indicator of symptomatic plaque rather than
stenosis or plaque burden alone.
Other intracranial plaque characteristics including contrast
FIG 3. A symptomatic patient with infarctions distal to the location of basilar artery plaque. Red arrows show the location of the plaque.Yellow
arrows show the location of infarctions on DWI. T1-weighted black-blood MR imaging shows high signal in the plaque (IPH). Postcontrast
T1-weighted image shows strong enhancement of the plaque.
Table 4: Diagnostic performance of intraplaque hemorrhage in
identifying symptomatic/asymptomatic basilar artery plaque
IPH-Positive
(n = 22)
IPH-Negative
(n = 104)
Symptomatic 21 45
Asymptomatic 1 59
Diagnostic performance
(%) (95% CI)
Specificity 98.3 (91.1–100.0)
Sensitivity 31.8 (20.9–44.4)
PPV 95.5 (74.4–99.3)
NPV 56.7 (52.6–60.8)
Note:—PPV indicates positive predict value; NPV, negative predict value.
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enhancement and minimal lumen area have been associated with
symptoms.24,25 We observed a similar relationship between con-
trast enhancement and symptom status in our study. A smaller
study examining the basilar artery with contrast-enhanced HR-
MRI observed wall enhancement in patients with recent infarc-
tion and also those who would go on to have ischemic events.26
Another study of intracranial atherosclerotic disease also con-
cluded that contrast enhancement was associated with culprit
plaques with a substantial odds ratio of approximately 35.25 Re-
search suggests that the vasa vasorum evolves with age and dem-
onstrates different distributions with less vasa vasorum in the in-
tracranial vasculature and differing distributions within the
cerebral vascular territories.27 Theoretically, enhancement of the
basilar artery wall could reflect physiologic enhancement of
the vasa vasorum rather than pathologic plaque enhancement,
which could reduce the specificity of vessel wall enhancement. An
improved understanding of the vasa vasorum may enhance the
specificity of basilar artery enhancement.
Further work is needed to histologically validate HR-MRI as-
sessment of IPH, with only 1 case of histologically verified intra-
cranial IPH demonstrated as T1-weighted hyperintense intra-
plaque signal on postmortem HR-MRI.28 Due to the reliance on
postmortem assessment of plaque, histologic validation of intra-
cranial plaque imaging characteristics is more challenging than in
the extracranial carotid artery plaque, which may be ascertained
following endarterectomy. While a study of intracranial plaque
characterization using ex vivo 3T HR-MRI in 53 postmortem
specimens determined relaxation times for many plaque compo-
nents, no IPH was encountered in these plaque specimens.29
Therefore, IPH detection on HR-MRI largely infers plaque char-
acteristics from existing extracranial atherosclerosis imaging
literature.
Our results cannot directly confer causality of IPH in symp-
tomatic stroke, and this cross-sectional study design cannot pro-
vide an assessment of future stroke risk. Prospective assessment of
IPH and subsequent stroke risk would extend the clinical rele-
vance of the findings of this study, and such data could be used in
risk-assessment calculations. HR-MRI can also determine IPH
timing and duration. Potentially, signal characteristics of IPH
could provide information on the onset of hemorrhage, and serial
examination of patients with ICAD exhibiting IPH could provide
insight into its natural history. Moreover, serial assessment of
intracranial IPH evolution while patients were on different phar-
macologic therapies might potentially provide objective informa-
tion regarding treatment efficacy.
In addition, there are technical limitations to our study. Our
study used a standard 2DT1-weighted black-blood fast spin-echo
sequence. The use of 3D sequences with higher resolution,30 bet-
ter T1-weighted contrast,31 and advanced blood-suppression
techniques (such as diffusion preparation32 or variable flip angle
train30) could potentially improve the identification of IPH.
However, the 3D high-resolution sequences can increase scan
time, the use of diffusion preparation can reduce the signal-to-
noise ratio and induce T2 contrast,32 and variable flip angle trains
can induce blurring with a wider point-spread function.30 All of
these limitations will need to be accounted for in future clinical
studies.
CONCLUSIONS
Evidence from this study suggests that IPH in the basilar artery
found onHR-MRI identifies atherosclerotic lesions that aremore
likely to be symptomatic regardless of the degree of stenosis. This
plaqueproperty appears tobe substantially associatedwith symptom
status, whereas many other factors, including plaque size, contrast
enhancement, anddegree of stenosis, donot. In the future, the use of
HR-MRI for the early detection of basilar artery IPHmay allow cli-
nicians to select individuals at greater risk of imminent stroke and
help provide optimal therapeutic intervention.
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